International Journal of Pharmaceutical and Phytopharmacological Research
ISSN (Print): 2250-1029
ISSN (Online): 2249-6084
Publish with eIJPPR Submission
2022   Volume 12   Issue 5

Quantitation of Ciprofloxacin by RP-HPLC from Active and Dosage Formulations

Ahsan Zamir Siddiqi1,2, Muneeba Akhtar3, Agha Zeeshan Mirza4*

 

1Research Institute of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Karachi, Karachi-75270, Pakistan.

2Highnoon Laboratories Limited, Lahore, Pakistan.     

3Department of Pharmaceutics, Faculty of Pharmacy, University of Central Punjab, Lahore-54782, Pakistan.

4Department of Chemistry, University of Karachi, Pakistan.


ABSTRACT

A simple, sensitive isocratic reversed-phase HPLC method for detecting and quantifying ciprofloxacin in pharmaceutical dosage forms has been developed and validated according to ICH guidelines. In the method, the separation was achieved on a C18 reversed-phase column with a mobile phase acetonitrile-water at a ratio of (80:20). The pH was adjusted to 2.7 using 85% of phosphoric acid with ultraviolet detection at 275.0 nm. A flow rate of 1.7 mL/minute was used at room temperature. The method's statistical evaluation was scrutinized through inter and intra-day precision assays, and it was found satisfactory through high accuracy and precision with a correlation coefficient of at least 0.9999. The quantification limit was 500 ng/mL, while this method's recovery was observed in the range of 99.01–101.19% and has the potential to be used for routine analysis in pharmaceuticals and clinical laboratories. The present method could also be useful to determine ciprofloxacin in human serum.

Key Words: Ciprofloxacin, RP-HPLC (Reverse Phase High-Performance Chromatography), Dosage form, Human serum


INTRODUCTION

Ciprofloxacin hydrochloride (Figure 1), the most frequently used quinolone [1], is available for oral use as hydrochloride monohydrate [2] and parenteral use as lactate [3]. It is slightly yellowish to light yellow crystals or crystalline powder, dissolved in water, and somewhat soluble in methanol [4]. It is thoroughly absorbed and is immediately excreted from the body under typical conditions with an elimination half-life of 3 to 5 hours. A polymer combination of ciprofloxacin showed more diffusivity and an extended-release rate connected to ciprofloxacin salt [5].

 

Figure 1. Ciprofloxacin

 

Several analytical techniques have been published to analyze ciprofloxacin in biological fluids and various pharmaceutical dosage forms (tablets, injectables, suppositories, gels, eye drops, etc.) [6-12]. A direct and sensitive HPLC method for determining ciprofloxacin in the influenza vaccine has been described [7] employing a mobile phase of acetonitrile/water/phosphoric acid. Its pH was adjusted to pH 3 with triethylamine. The separation was obtained at a flow rate of 0.6 mLmin-1 at 280 nm. A method was mentioned for ciprofloxacin with other quinolones using a mobile phase consisting of water-acetonitrile (50:50, v/v) with a pH of 2.9 adjusted with phosphoric acid. Different wavelengths were applied at a flow rate of 1 mLmin-1, while propylparaben was used as an internal standard [8]. A liquid chromatographic method was also reported for ciprofloxacin's concurrent determination with rosuvastatin in formulations and human serum. The separation was achieved using a mobile phase of methanol-water at a ratio of 90:10 v/v. The flow rate was 1 mLmin-1, the pH of the mobile phase was pH 3, and drugs were monitored at 255 nm [9]. Similarly, an HPLC–UV method was described for the determination of ciprofloxacin in human plasma with a phosphate buffer (pH 2.7) and acetonitrile (77:23, v/v), and the drug was detected at 277 nm [10, 13-15].

The suggested task deals with the precise analysis of ciprofloxacin using a straightforward, moderate-cost, and less time-consuming HPLC method with significant accuracy and good LOQ (Limit of detection) value. The technique contains readily available chemicals, solvents, and an internal standard suitable for routine analysis.

MATERIALS AND METHODS

Material and reagents

CiproxinTM 250 mg tablets (Bayer Pakistan Pvt. Ltd. Karachi) were purchased from the local pharmacy, while mebeverine HCl (internal standard) was a kind gift from AGP (Private) Limited Karachi. De-ionized water was prepared in the lab from double distilled water, while all other solvents were HPLC grade (Merck Germany). Shimadzu Corporation Japan's chromatographic system consisted of an LC-10 AT VP pump and SPD-10 AV VP UV-visible detector. The separation was achieved on the µ Bondapak 125A C-18 10 µm column.

 

Analytical procedure

10 mg of ciprofloxacin hydrochloride and internal standard (mebeverine hydrochloride) were dissolved in water in a 100 mL volumetric flask separately, with the same solvent. The concentrations of these immediate solutions were 100 ppm. For the stock solution preparation, 10 mL of ciprofloxacin (100 ppm) was taken in a 100 mL volumetric flask with water. The concentrations of these stock solutions were 10 ppm, from which standard working solutions of desired concentrations were prepared.

Different dilutions ranging from 0.50, 1.0, 1.50,..3.0 ppm were prepared from the stock solution of ciprofloxacin. For this purpose, 5, 10, 15,…..30 mL of stock solutions were pipetted out in different 100 mL volumetric flasks and made up to the mark with the same solvent (water) to have the required concentrations of 0.50, 1.0, 1.50, . . . 3.0 ppm, respectively, and in all solutions, added 1 mL of the internal standard (primary solution) added as internal standard became 5 ppm of final concentration. Six different concentrations of each sample were analyzed. For intra-day precision, different concentrations of every compound were investigated on a similar date and injected four times. The mean value of each concentration was used to calculate %RSD. Generally, satisfactory repeatability of the outcome in one day and alternate days was observed. Lower RSD values showed that the method is reliable to analyze both drugs separately.

RESULTS AND DISCUSSION

Many methods have already been reported for estimations of ciprofloxacin [6-12] and but the present method is straightforward and is validated according to ICH (International Conference on Harmonization) guidelines [16]. All of the parameters were found under the limits of ICH guidelines, and the chromatogram of the analyte revealed that the method was specific and no peak of internal standard interfered, and can be considered selective.

The analysis was conceded in isocratic conditions using a mobile phase acetonitrile-water (80:20), while pH 2.7 was adjusted using phosphoric acid (85%). The flow rate of 1.7 mLminutes-1 was used, and all experiments were performed at room temperature at 275.0 nm. The retention time of both the drug and internal standard were 1.52 and 2.7 minutes, respectively. The method was found linear (r2=0.9999), accurate (%RSD>2%), precise, specific, and sensitive (DL= 120 ngmL-1 and QL=500 ngmL-1).

 

Discussion

Linearity and regression analysis

The present method is linear over a range of 0.5 to 3.0 ppm, and all the calibration curves have a correlation coefficient value of at least 0.9999 (Table 1).

 

Table 1. Statistical regression characteristics of method

 

Day 1

Day 2

Day 3

Day 4

Correlation coefficient (R2)

0.9999

0.9999

0.9999

0.9999

Standard error of estimate

0.0041

0.0012

0.0036

0.0011

Standard error

0.0038

0.0011

0.0034

0.0011

Intercept

-0.0014

0.0005

0.0006

-0.0000

P Value

0.0000

0.0000

0.0000

0.0000

Slope

1

1

1

1

 

 Accuracy

Accuracy was performed according to the guidelines published by ICH [16]. The recovery data expressed in Table 2 showed that the method is accurate for determining and quantifying ciprofloxacin.

 

Table 2. Recovery of Ciprofloxacin in dosage form

Serial No.

*Conc. ppm

Peak area of sample

%

Recovery

mg/tablet

Conc.

1

0.5

70964

99.229

248.073

0.4961

2

1

141618

99.012

247.532

0.9901

3

1.5

215867

100.61

251.54

1.5092

4

2

289465

101.19

252.975

2.0238

5

2.5

356674

99.748

249.37

2.4937

6

3

430762

100.38

250.974

3.0116

*Concentration

Precision

Like accuracy, the method's precision was also performed using the same guidelines [16].

The precision was examined regarding repeatability, and intra-day precision was analyzed on the same day using six ciprofloxacin concentrations. Table 3 summarizes the relative standard deviation (RSD).

 

 

Table 3. Intra and inter day variations in the analysis of ciprofloxacin hydrochloride

Serial

Concn

Area under curve

Standard

Deviation

Relative

standard

deviation

%

Recovery

Recovered

Concentration

Time

 

No.

ppm

8:00

11:00

14:00

17:00

Mean

Day 1

                   

1

0.5

71563

71502

71488

71426

71494.75

56.22

0.0008

99.97

0.4999

2

1

143011

142820

141983

141992

142451

541.44

0.0038

99.59

0.996

3

1.5

214549

214371

214052

214364

214334

206.57

0.001

99.9

1.4985

4

2

287117

287217

286659

287009

287000.5

242.99

0.0008

100.38

2.0066

5

2.5

357283

357212

357110

356991

357149

127.03

0.0004

99.88

2.497

6

3

429201

429228

428967

428964

429090

144.19

0.0003

100

3

Day 2

                   

1

0.5

73892

73659

73610

73707

73717

123.2

0.0017

100.23

0.5012

2

1

147457

146831

147325

147013

147156.5

285.91

0.0019

100.04

1.0005

3

1.5

221113

220219

220413

220453

220549.5

389.32

0.0018

99.96

1.4995

4

2

294128

293496

294428

294338

294097.5

420.24

0.0014

99.97

1.9995

5

2.5

368339

367657

368009

368173

368044.5

291.35

0.0008

100.09

2.5023

6

3

442114

440367

441428

441093

441250.5

726.3

0.0016

100

3

Day 3

                   

1

0.5

81029

81001

80994

80983

81001.75

19.62

0.0002

99.99

0.5

2

1

162116

162453

161357

161637

161890.8

488.58

0.003

99.92

0.9992

3

1.5

243246

243179

242996

243004

243106.3

125.74

0.0005

100.03

1.5005

4

2

325561

325229

325006

324811

325151.8

321.87

0.001

100.34

2.0069

5

2.5

405332

402961

405075

404883

404562.8

1083.56

0.0027

99.88

2.4971

6

3

486229

486634

485630

485690

486045.8

475.75

0.001

100

3

Day 4

                   

1

0.5

83802

83714

83696

83755

83741.75

47.15

0.0006

100.24

0.5012

2

1

167003

167394

166469

166845

166927.8

383.12

0.0023

99.9

0.9991

3

1.5

250119

250964

250328

250419

250457.5

360.27

0.0014

99.93

1.499

4

2

334094

334267

334064

334562

334246.8

228.42

0.0007

100.02

2.0005

5

2.5

418229

417886

417931

417829

417968.8

178.45

0.0004

100.06

2.5016

6

3

501009

501439

500884

501634

501241.5

353.52

0.0007

100

3

 

 

System suitability

System suitability is the parameter that assists in checking the behavior of the system and was evaluated by analyzing the symmetry of the ciprofloxacin, internal standard (mebeverine hydrochloride), peaks, theoretical plates of the column (>2000), and the resolution between the peaks of internal standard and drugs.

Specificity

Specificity is ensured by the separation of the internal standard and ciprofloxacin. The technique demonstrated a resolution between the internal standard and ciprofloxacin. HPLC chromatogram showed that extraneous peaks by adding an internal standard are the baseline resolved from the parent analyte (Figure 2).

 

 

Figure 2. Representative chromatogram of ciprofloxacin and internal standard

 

 

Quantification limit

The quantification limit is the lowest concentration of an analyte in a sample determined under sufficient precision and accuracy using the stated experimental condition. The limit of quantification of the developed method was found to be 500 ngmL-1.

 

Detection limit

The lowest detected concentration of an analyte had not necessarily been quantitated under the stated experimental conditions. The detection limit was found to be 120 ngmL-1 of the developed method.

CONCLUSION

The proposed method offered an excellent outcome of the quantitative resolution of the drug molecules. The sample recoveries from the formulation were good in agreement and, with the label claims, suggested no interference of excipients in ciprofloxacin estimation. The recommended method with very simple mathematical content is more reliable and fast. The analysis time robustly supports us in relating these calibration models for regular investigation.

Acknowledgments: None

Conflict of interest: None

Financial support: None

Ethics statement: None

References

[1]    Sultana N, Arayne MS, Siddiqi A, Mirza AZ. Synthesis and antibacterial studies of ciprofloxacin-metal complexes. J Chin Pharm Sci. 2019;28(6):422-9.

[2]    Ciprofloxacin product information monograph, Marcel Dekker inc; 1988. p. 6.

[3]    United States Pharmacopoeia 23, National Formulary 18. The United States Pharmacopoeial Convention inc., 1995. p. 379, 1104.

[4]    Reynolds JE, Kathleen P. Martindale, The Extra Pharmacopoeia. Royal Pharm Soc. 1996;p. 207-10, 1346-7.

[5]    Schierholz JM, Rump A, Pulverer G. New antiinfectious biomaterials. Ciprofloxacin containing polyurethanes as potential drug delivery systems to prevent foreign-body infections. Arzneimittelforschung. 1997;47(1):70-4.

[6]    Siddiqui FA, Arayne MS, Sultana N, Mirza AZ, Qureshi F, Zuberi MH. Facile and manifest spectrophotometric methods for the determination of six quinolone antibiotics in pharmaceutical formulations using iron salts. Med Chem Res. 2010;19:1259-72.

[7]    Forlay-Frick P, Nagy ZB, Fekete J. Validated determination of ciprofloxacin in influenza vaccine by RP-HPLC. J Liq Chromatogr Relat Technol. 2001;24(6):827-36.

[8]    Siddiqui FA, Arayne MS, Sultana N, Qureshi F, Mirza AZ, Shehnaz H. Quantitative determination of fluoroquinolinic antibiotics: pefloxacin, norfloxacin, ciprofloxacin and ofloxacin in pharmaceutical preparations and human serum by high-performance liquid chromatography using multi-wavelength calibration technique. Chem Anal. 2009;54(6):1465-85.

[9]    Arayne MS, Sultana N, Tabassum A. Facile LC‐UV methods for simultaneous monitoring of ciprofloxacin and rosuvastatin in API, formulations and human serum. Biomed Chromatogr. 2015;29(2):202-9.

[10] Vella J, Busuttil F, Bartolo NS, Sammut C, Ferrito V, Serracino-Inglott A, et al. A simple HPLC–UV method for the determination of ciprofloxacin in human plasma. J Chromatogr B. 2015;989:80-5.

[11] Vishnuraj AR, Gurupadayya B, Kathirvel S. Stability indicating analytical method development and validation of ciprofloxacin by RP-HPLC with fluorescence detector. Int J Pharm Qual Assur. 2021;12:51-6. doi:10.25258/ijpqa.12.1.8

[12] Shamshad H, Mirza AZ. Application of RP-HPLC method for the simultaneous determination of cetirizine in the presence of quinolones. Future J Pharm Sci. 2021;7(1):1-6.

[13] Nakagawa N, Odanaka K, Ohara H, Kisara S. Evaluation of drug information literacy gained through e-learning to prepare students for practical pharmacy experience. J Adv Pharm Educ Res. 2021;11(4):111-5.

[14] Alkandahri MY, Patala R, Berbudi A, Subarnas A. Antimalarial activity of curcumin and kaempferol using structure-based drug design method. J Adv Pharm Educ Res. 2021;11(4):87-90.

[15] Ebrahimi S, Shohrati M, Najafian B. Drug Use Evaluation of Intravenous Immunoglobulin (IVIG) in a Hospital in Iran. Entomol Appl Sci Lett. 2021;8(2):57-61.

[16] ICH topic-Topic Q2A. validation of analytical procedures, international conference on harmonization of technical requirements for registration of pharmaceuticals for human use. 2002. Available from: http://www.ich.org/pdflch/q2a.pdf

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

International Journal of Pharmaceutical and Phytopharmacological Research
© 2024 All rights reserved